COYA

Coya Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in Houston, Texas, dedicated to developing innovative therapies that enhance regulatory T cell (Treg) functionality to treat autoimmune and neurodegenerative diseases. Utilizing its proprietary platform, Coya is advancing a promising pipeline with a focus on critical conditions, including Multiple Sclerosis and Amyotrophic Lateral Sclerosis. As the company progresses through its clinical trials, it is well-positioned to provide transformative treatments that address significant unmet medical needs, potentially reshaping the future of immune-mediated therapies.